Early recognition of oncologic emergencies deemed ‘crucial’
“Early recognition of these emergencies is crucial, and there are simple initial interventions that can make a big difference in patient outcomes.”
“Early recognition of these emergencies is crucial, and there are simple initial interventions that can make a big difference in patient outcomes.”
Helping trainees—and hospitalists—move forward
Physicians discuss the new monoclonal antibody nirsevimab RSV treatments for infants and the vaccine for pregnant people.
A novel therapy has a favorable safety profile, and more like it may be on the way.
New results come from an interim analysis of a phase 3 randomized trial comparing maintenance therapy with ribociclib plus endocrine therapy with an aromatase inhibitor…
Adding immunotherapy resulted in a 40% reduction in risk of death, compared with chemotherapy alone, for women with advanced cervical cancers expressing PD-L1.
Vorasidenib was associated with a significant delay in time to disease progression when compared with placebo, in a new study.
After 6 months, patients who received telephone coaching and health education lost 9.7 pounds.
Results of a new study were particularly notable for Black patients, for whom there was a consistent increase in receiving therapy and a decrease in…
The immune checkpoint inhibitor nivolumab affords unprecedented improvement in “harmonizing” treatment for adult and pediatric Hodgkin lymphoma patients.
Survival from pediatric acute lymphoblastic leukemia (ALL) in a Mexican hospital improved significantly through a close cross-border collaboration with a nearby U.S. center that provided…